Development of potential CDK9 inhibitors through pharmacophore-based virtual screening, 3D-QSAR, molecular docking, MD simulation, and in vitro anticancer evaluation. [PDF]
Reddyrajula R +8 more
europepmc +1 more source
Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors. [PDF]
Gallego-Yerga L +7 more
europepmc +1 more source
Identification and Biological Validation of MMP-12 Inhibitors Guided by Pharmacophore-Based Virtual Screening and Docking Studies. [PDF]
Almutairi S +4 more
europepmc +1 more source
Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease. [PDF]
El-Ashrey MK +4 more
europepmc +1 more source
Ganesh Kumar Veeramachaneni, K Kranthi Raj, Leela Madhuri Chalasani, Jayakumar Singh Bondili, Venkateswara Rao Talluri Department of Biotechnology, K L University, Guntur, India Background: Obesity is a progressive metabolic disorder in the current ...
Raj KK +4 more
core
Identification of a peptide inhibitor disrupting the PCSK9-LDLR interaction <i>via</i> pharmacophore-based virtual screening, molecular dynamics simulations and <i>in vitro/vivo</i> evaluation. [PDF]
Wu W +5 more
europepmc +1 more source
Pharmacophore-Based Virtual Screening of Novel Competitive Inhibitors of the Neurodegenerative Disease Target Kynurenine-3-Monooxygenase. [PDF]
Gotina L +4 more
europepmc +1 more source
Identification of new triazoloquinoxaline amine derivatives with potent modulatory effects against Toll-like receptor 7 through pharmacophore-based virtual screening and molecular docking approaches. [PDF]
Harooni NS +5 more
europepmc +1 more source
A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations. [PDF]
Susanti NMP +3 more
europepmc +1 more source
Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation for Identification of a Novel DNA Gyrase B Inhibitor with Benzoxazine Acetamide Scaffold. [PDF]
Elseginy SA, Anwar MM.
europepmc +1 more source

